Literature DB >> 11934642

Osteoclastic acidification pathways during bone resorption.

A-V Rousselle1, D Heymann.   

Abstract

Osteoclasts resorb bone by attaching to the surface and then secreting protons into an extracellular compartment formed between osteoclast and bone surface. This secretion is necessary for bone mineral solubilization and the digestion of organic bone matrix by acid proteases. This study summarizes the characterization and role of each type of ion transport and defines the main biochemical mechanisms involved in the dissolution of bone mineral during bone resorption. The primary mechanism responsible for acidification of the osteoclast-bone interface is vacuolar H+-adenosine triphosphatase (ATPase) coupled with Cl- conductance localized to the ruffled membrane. Carbonic anhydrase II (CAII) provides the proton source for extracellular acidification by H+-ATPase and the HCO3- source for the HCO3-/Cl- exchanger. Whereas some transporters are responsible for the bone resorption process, others are essential for pH regulation in the osteoclast. The HCO3-/Cl- exchanger, in association with CAII, is the major transporter for maintenance of normal intracellular pH. An Na+/H+ antiporter may also contribute to the recovery of intracellular pH during early osteoclast activation. Once this mechanism has been rendered inoperative, another conductive pathway translocates the protons and modulates cytoplasmic pH. Inward-rectifying K+ channels may also be involved by compensating for the external acidification due to H+ transport. These different effects of transport processes, either on bone resorption or pH homeostasis, increase the number of possible sites for pharmacological intervention in the treatment of metabolic bone diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934642     DOI: 10.1016/s8756-3282(02)00672-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  50 in total

1.  Metabolic activation stimulates acid secretion and expression of matrix degrading proteases in human osteoblasts.

Authors:  M George; B Stein; O Müller; M Weis-Klemm; T Pap; W J Parak; W K Aicher
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

2.  Proteoglycans and osteolysis.

Authors:  Marc Baud'Huin; Céline Charrier; Gwenola Bougras; Régis Brion; Frédéric Lezot; Marc Padrines; Dominique Heymann
Journal:  Methods Mol Biol       Date:  2012

3.  V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.

Authors:  De-Qin Yang; Shengmei Feng; Wei Chen; Haibo Zhao; Christie Paulson; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

Review 4.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

5.  Expression profile of carbonic anhydrases in articular cartilage.

Authors:  Melissa Schultz; Wu Jin; Abdul Waheed; Berton R Moed; William Sly; Zijun Zhang
Journal:  Histochem Cell Biol       Date:  2011-07-08       Impact factor: 4.304

6.  Resorption behavior of a nanostructured bone substitute: in vitro investigation and clinical application.

Authors:  Christoph Reichert; Werner Götz; Susanne Reimann; Ludger Keilig; Martin Hagner; Christoph Bourauel; Andreas Jäger
Journal:  J Orofac Orthop       Date:  2013-03-08       Impact factor: 1.938

7.  Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice.

Authors:  Yasuhisa Abe; Kousuke Iba; Koichi Sasaki; Hironori Chiba; Kumiko Kanaya; Tomoyuki Kawamata; Kimimitsu Oda; Norio Amizuka; Muneteru Sasaki; Toshihiko Yamashita
Journal:  J Bone Miner Metab       Date:  2014-03-16       Impact factor: 2.626

8.  Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.

Authors:  Anita V Neutzsky-Wulff; Mette G Sørensen; Dino Kocijancic; Diana J Leeming; Morten H Dziegiel; Morten A Karsdal; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-06-01       Impact factor: 2.362

9.  Osteogenic activity of locally applied small molecule drugs in a rat femur defect model.

Authors:  Jessica A Cottrell; Francis M Vales; Deborah Schachter; Scott Wadsworth; Rama Gundlapalli; Rasesh Kapadia; J Patrick O'Connor
Journal:  J Biomed Biotechnol       Date:  2010-06-16

Review 10.  Acidosis and Urinary Calcium Excretion: Insights from Genetic Disorders.

Authors:  R Todd Alexander; Emmanuelle Cordat; Régine Chambrey; Henrik Dimke; Dominique Eladari
Journal:  J Am Soc Nephrol       Date:  2016-07-28       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.